Sierra Capital Partners Custom Case Solution & Analysis

Sierra Capital Partners: Evidence Brief

1. Financial Metrics

• Fund II Size: $250M (Source: Case Intro).
• Management Fee: 2% annually on committed capital (Source: Exhibit 1).
• Carried Interest: 20% performance fee subject to 8% hurdle rate (Source: Exhibit 1).
• Target Internal Rate of Return (IRR): 25%+ (Source: Paragraph 4).
• Proposed Investment: $40M for a 35% equity stake in TechFlow Logistics (Source: Exhibit 3).

2. Operational Facts

• Investment Horizon: 5-7 years (Source: Paragraph 2).
• TechFlow Logistics: Logistics SaaS provider, 18% annual growth, high customer churn (12% per annum) (Source: Exhibit 4).
• Sierra Capital Team: Managing Partners (2), Associates (4). Limited administrative support (Source: Paragraph 6).
• Geography: Focus on North American mid-market (Source: Paragraph 3).

3. Stakeholder Positions

• Managing Partner A: Favors TechFlow for growth potential, dismisses churn concerns (Source: Paragraph 8).
• Managing Partner B: Concerned about churn and valuation; prefers lower entry price (Source: Paragraph 9).
• TechFlow Founders: Seeking capital for R&D; resistant to board control (Source: Exhibit 5).

4. Information Gaps

• Customer Acquisition Cost (CAC) vs Lifetime Value (LTV) ratios for TechFlow are missing.
• Detailed competitive landscape analysis for the logistics SaaS sector is absent.
• Specific exit strategy for the TechFlow investment is not defined.

Strategic Analysis

Core Strategic Question

Should Sierra Capital deploy $40M into TechFlow Logistics given the tension between high revenue growth and material customer attrition?

Structural Analysis

• Value Chain: TechFlow occupies a critical node in logistics, but their high churn indicates a failure in product stickiness or post-sales service.
• Porter Five Forces: High buyer power in logistics SaaS forces low switching costs, explaining the churn.

Strategic Options

• Option 1: Proceed with Investment at Lower Valuation. Cap investment at $30M for 35% stake to account for churn risk. Trade-off: May alienate founders.
• Option 2: Conditional Investment. Invest $40M in tranches based on churn reduction to <5% within 12 months. Trade-off: Complex governance; requires active operational oversight.
• Option 3: Pass. The churn profile suggests a fundamental product defect. Trade-off: Opportunity cost of missing potential market leader.

Preliminary Recommendation

Option 2. The potential return justifies the capital, but only if the churn is structural, not systemic. Tranching capital forces founders to prioritize retention over raw acquisition.

Implementation Roadmap

Critical Path

1. Due Diligence: Conduct deep-dive churn cohort analysis (Weeks 1-4).
2. Term Sheet Negotiation: Insert performance-linked tranche clauses (Weeks 5-6).
3. Operational Integration: Appoint a Sierra Operating Partner to the board to oversee customer success metrics (Post-close).

Key Constraints

• Founding Team Alignment: Founders prioritize growth; Sierra must align incentives toward retention.
• Capital Availability: Sierra must ensure sufficient liquidity for subsequent tranches.

Risk-Adjusted Strategy

Implement a quarterly review cycle tied to the churn metric. If churn remains above 10% by month 9, trigger a mandatory strategic pivot or exit. This mitigates the risk of capital erosion in a failing business model.

Executive Review and BLUF

BLUF

Sierra Capital should proceed with the TechFlow investment only under a performance-contingent structure. The current 12% churn rate is unsustainable for a SaaS business seeking a 25% IRR. Without a contractual mandate to lower churn, the investment relies on finding a greater fool at exit rather than underlying business health. The deal must be structured with capital tranches linked to specific retention milestones. If the founders reject these terms, pass. The risk of losing the deal is less than the risk of owning a broken business model.

Dangerous Assumption

The assumption that revenue growth can mask high churn. In SaaS, churn is not just lost revenue; it is a signal of product-market misalignment.

Unaddressed Risks

• Competitive Displacement: If churn is high due to better features from competitors, capital infusion will not solve the problem. (Probability: High).
• Governance Impasse: Founders may resist board intervention, leading to a dysfunctional relationship. (Probability: Medium).

Unconsidered Alternative

A structured debt-equity hybrid. Provide $20M in equity and $20M in convertible debt. This protects the downside while providing the needed capital for R&D.

Verdict: APPROVED FOR LEADERSHIP REVIEW